Table 2. Association of anti HP treatment on BMI and nutritional factors of HP positive patients (Group 2).
| variables | Before treatment | After 6 months treatment | P value |
| BMI( kg/m2) | 25.02±4.4 | 24.4±4.4 | 0.001** |
| Alb(mg/dL) | 4.2±0.6 | 3.7± 0.5 | <0.001 |
| TG(g/ dL) | 140.1±76.4 | 155.7±99.3 | 0.2* |
| Chol(mg/ dL) | 179.7±41.8 | 159.9±36.2 | 0.001 |
| BUN(mg/ dL) | 90±45.1 | 67.5±16.4 | 0.005* |
| Cr(mg/ dL) | 10.1±3.2 | 9.6±2.8 | 0.32 |
| Hb(g/ dL) | 10.7±2.2 | 11.6±1.7 | 0.03 |
| Ca(mg/ dL) | 9.7±1.1 | 9.2±0.9 | 0.02 |
| P(mg/ dL) | 6.2±3.1 | 5.8±1.7 | 0.48 |
*Wilcoxon signed test
**repeated measure test